vs

Side-by-side financial comparison of National Bank Holdings Corp (NBHC) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.

National Bank Holdings Corp is the larger business by last-quarter revenue ($126.8M vs $66.0M, roughly 1.9× SOLENO THERAPEUTICS INC). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs 16.4%, a 23.0% gap on every dollar of revenue.

Old National Bank is an American regional bank with nearly 200 retail branches operated by Old National Bancorp and based in Chicago and Evansville, Indiana. With assets at $48.5 billion and 250 banking centers, Old National Bancorp is the largest financial services bank holding company headquartered in Indiana and one of the top 30 banking companies in the U.S. Old National Bank has locations in Illinois, Indiana, Iowa, Kentucky, Michigan, Minnesota, Tennessee, and Wisconsin.

SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.

NBHC vs SLNO — Head-to-Head

Bigger by revenue
NBHC
NBHC
1.9× larger
NBHC
$126.8M
$66.0M
SLNO
Higher net margin
SLNO
SLNO
23.0% more per $
SLNO
39.4%
16.4%
NBHC

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
NBHC
NBHC
SLNO
SLNO
Revenue
$126.8M
$66.0M
Net Profit
$20.8M
$26.0M
Gross Margin
98.3%
Operating Margin
33.5%
Net Margin
16.4%
39.4%
Revenue YoY
Net Profit YoY
-14.2%
134.0%
EPS (diluted)
$0.46
$0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NBHC
NBHC
SLNO
SLNO
Q1 26
$126.8M
Q4 25
$100.6M
Q3 25
$108.9M
$66.0M
Q2 25
$104.5M
$32.7M
Q1 25
$102.1M
Q4 24
$101.3M
Q3 24
$106.0M
Q2 24
$97.6M
Net Profit
NBHC
NBHC
SLNO
SLNO
Q1 26
$20.8M
Q4 25
$16.0M
Q3 25
$35.3M
$26.0M
Q2 25
$34.0M
$-4.7M
Q1 25
$24.2M
Q4 24
$28.2M
Q3 24
$33.1M
Q2 24
$26.1M
Gross Margin
NBHC
NBHC
SLNO
SLNO
Q1 26
Q4 25
Q3 25
98.3%
Q2 25
97.9%
Q1 25
Q4 24
Q3 24
Q2 24
Operating Margin
NBHC
NBHC
SLNO
SLNO
Q1 26
Q4 25
19.0%
Q3 25
39.6%
33.5%
Q2 25
39.8%
-20.0%
Q1 25
29.2%
Q4 24
34.3%
Q3 24
37.6%
Q2 24
32.5%
Net Margin
NBHC
NBHC
SLNO
SLNO
Q1 26
16.4%
Q4 25
15.9%
Q3 25
32.4%
39.4%
Q2 25
32.6%
-14.4%
Q1 25
23.7%
Q4 24
27.8%
Q3 24
31.2%
Q2 24
26.8%
EPS (diluted)
NBHC
NBHC
SLNO
SLNO
Q1 26
$0.46
Q4 25
$0.42
Q3 25
$0.92
$0.47
Q2 25
$0.88
$-0.09
Q1 25
$0.63
Q4 24
$0.72
Q3 24
$0.86
Q2 24
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NBHC
NBHC
SLNO
SLNO
Cash + ST InvestmentsLiquidity on hand
$472.8M
$498.9M
Total DebtLower is stronger
$202.1M
Stockholders' EquityBook value
$1.7B
$494.8M
Total Assets
$12.6B
$599.9M
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NBHC
NBHC
SLNO
SLNO
Q1 26
$472.8M
Q4 25
$417.1M
Q3 25
$555.6M
$498.9M
Q2 25
$296.5M
$286.8M
Q1 25
$246.3M
Q4 24
$127.8M
Q3 24
$180.8M
Q2 24
$145.0M
Total Debt
NBHC
NBHC
SLNO
SLNO
Q1 26
$202.1M
Q4 25
$54.5M
Q3 25
$54.7M
Q2 25
$54.4M
Q1 25
$54.6M
Q4 24
$54.5M
Q3 24
$54.4M
Q2 24
$54.4M
Stockholders' Equity
NBHC
NBHC
SLNO
SLNO
Q1 26
$1.7B
Q4 25
$1.4B
Q3 25
$1.4B
$494.8M
Q2 25
$1.4B
$240.1M
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.2B
Total Assets
NBHC
NBHC
SLNO
SLNO
Q1 26
$12.6B
Q4 25
$9.9B
Q3 25
$10.2B
$599.9M
Q2 25
$10.0B
$332.3M
Q1 25
$10.1B
Q4 24
$9.8B
Q3 24
$10.0B
Q2 24
$10.0B
Debt / Equity
NBHC
NBHC
SLNO
SLNO
Q1 26
0.12×
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.04×
Q2 24
0.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NBHC
NBHC
SLNO
SLNO
Operating Cash FlowLast quarter
$43.5M
Free Cash FlowOCF − Capex
$43.5M
FCF MarginFCF / Revenue
65.8%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.67×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NBHC
NBHC
SLNO
SLNO
Q1 26
Q4 25
$162.4M
Q3 25
$52.4M
$43.5M
Q2 25
$32.3M
$-12.6M
Q1 25
$39.6M
Q4 24
$155.3M
Q3 24
$47.0M
Q2 24
$31.9M
Free Cash Flow
NBHC
NBHC
SLNO
SLNO
Q1 26
Q4 25
Q3 25
$43.5M
Q2 25
$-12.6M
Q1 25
Q4 24
Q3 24
Q2 24
FCF Margin
NBHC
NBHC
SLNO
SLNO
Q1 26
Q4 25
Q3 25
65.8%
Q2 25
-38.6%
Q1 25
Q4 24
Q3 24
Q2 24
Capex Intensity
NBHC
NBHC
SLNO
SLNO
Q1 26
Q4 25
Q3 25
0.0%
Q2 25
0.0%
Q1 25
Q4 24
Q3 24
Q2 24
Cash Conversion
NBHC
NBHC
SLNO
SLNO
Q1 26
Q4 25
10.13×
Q3 25
1.48×
1.67×
Q2 25
0.95×
Q1 25
1.64×
Q4 24
5.51×
Q3 24
1.42×
Q2 24
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NBHC
NBHC

Net Interest Income$108.8M86%
Noninterest Income$18.0M14%

SLNO
SLNO

Segment breakdown not available.

Related Comparisons